Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Common Stock | Options Exercise | $143K | +1.83K | +4.13% | $78.48 | 46.1K | May 11, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$121K | -810 | -1.76% | $149.49 | 45.3K | May 11, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Stock Appreciation Right (right to purchase) 2014 | Options Exercise | $0 | -3.85K | -100% | $0.00* | 0 | May 11, 2023 | Common Stock | 3.85K | $78.48 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents (i) 2,020 shares sold to pay the exercise price the purchase of common stock, and (ii) 810 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 1,018 shares. |
F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |